Cosmecca Korea sold substantially more in the third quarter of 2026 without earning much more operating profit. Its 6 November announcement put group revenue at KRW 247.5 billion, up 35.7% year on year. Operating profit was KRW 27.2 billion, an increase of just 0.1%.

The Korean operation was not short of orders. It passed KRW 200 billion in quarterly revenue for the first time. But a busy factory and a stronger group profit are not the same thing: costs, delivery pressures and performance in other countries determine how much of the extra business reaches the bottom line.

That makes this quarter more interesting than a simple growth headline. It is a story about absorbing demand. For manufacturers serving fast-growing brands, keeping a delivery promise can be commercially valuable even when the immediate order is less profitable than hoped.

Korea Crossed a New Quarterly Threshold

The Korean entity generated KRW 201.1 billion in revenue, up 54.9%, and KRW 23.4 billion in operating profit, up 61.3%. Skincare sales grew 92% and represented approximately 80% of that entity's revenue. The percentage belongs to the Korean business, not automatically to the whole group.

Those results establish real demand. They do not by themselves explain the group's almost flat profit. To see the difference, it is necessary to move beyond the busiest part of the company and look at what fulfilling the orders required, as well as what happened elsewhere.

Meeting the Deadline Had a Cost

In its 9 November review, Hana Securities attributed pressure on the Korean operation's quarter-on-quarter margin to greater outsourcing and a roughly KRW 2 billion incentive payment. The analyst described a business using overtime and outside production to fulfil demand. This is the broker's explanation, rather than a separate audited finding.

The trade-off is familiar to any growing supplier: refuse work, risk a late delivery or pay more to get the order out. Our interpretation is that protecting a customer relationship can justify a temporary cost, but only if the next orders can be served more efficiently. A one-quarter sacrifice is not yet evidence of a permanently better business.

The US Business Faced a Harder Comparison

Hana's results table showed US revenue down 26.1% and operating profit down 61.0% year on year. Its review linked the comparison to a large customer's high order volume a year earlier. MoneyToday reported that China, meanwhile, remained loss-making despite revenue growth.

The group margin fell to about 11.0%, from 14.9% a year earlier. That is the clearest expression of the gap between sales growth and earnings growth. It also shows why performance in one country cannot stand in for the whole business, even when that country is setting records.

Group revenue growth+35.7%

Q3 2026 versus Q3 2025; revenue of approximately KRW 247.5 billion.

Source 1
Group operating-profit growth+0.1%

Same quarters; operating profit of approximately KRW 27.2 billion.

Source 1
Group operating margin11.0%

Q3 2026, compared with 14.9% in Q3 2025 in Hana Securities' results table.

Source 2

After the Rush Comes the Production Work

Cosmecca said it planned to diversify raw-material and packaging supply and improve production through automation. It also set a KRW 1 trillion consolidated revenue target for 2027. That is a company goal, not a result already achieved.

The most useful next chapter would show how these changes affect delivery and cost per order, not just how much larger the revenue number becomes. More sales can strengthen the customer base; better execution determines whether that scale produces a dependable profit. This quarter demonstrates the first part more clearly than the second.

DSML research · 16 November 2026